Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Efficacy of Kanglaite Gelcaps in Prostate Cancer

This study has been terminated.
(Sponsor decision)
Information provided by (Responsible Party):
KangLaiTe USA Identifier:
First received: November 28, 2011
Last updated: April 11, 2014
Last verified: April 2014
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2013
  Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)